Information Journal Paper
APA:
Copy. (2017). Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A. BLOOD COAGULATION AND FIBRINOLYSIS, 28(6), 425-430. SID. https://sid.ir/paper/738712/en
Vancouver:
Copy. Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A. BLOOD COAGULATION AND FIBRINOLYSIS[Internet]. 2017;28(6):425-430. Available from: https://sid.ir/paper/738712/en
IEEE:
Copy, “Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A,” BLOOD COAGULATION AND FIBRINOLYSIS, vol. 28, no. 6, pp. 425–430, 2017, [Online]. Available: https://sid.ir/paper/738712/en